Shares of Abbott Laboratories (ABT) lost ~7% to reach a 52-week low on Thursday after the MedTech giant lowered its full-year earnings outlook, indicating an impact from its recent acquisition of ...

Exact Sciences deal adds $3 billion in incremental sales in 2026, CEO Ford says Nutrition sales fell 6%; diabetes and heart devices face competition, analysts note Middle East conflict causes minor ...

The medical test-making company Abbott has finalized its acquisition of Exact Sciences, the Madison-based maker of cancer screening and diagnostic tests, it said in a March 23 announcement. The deal, ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

MADISON, Wis. -- Abbott expects to close its acquisition of Exact Sciences on Monday, the healthcare giant said. Madison-based Exact Sciences is known for its cancer detection technology such as ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

A collage of images of Schrödinger, his 100-year-old paper and his equation. The Schrödinger equation was integral to changing the way the world saw chemistry as a science. Credit: Madeline Monroe/TKH ...

A hundred years ago this week, at the height of the quantum revolution, Austrian physicist Erwin Schrödinger submitted a manuscript for publication. Its centerpiece was an innocuous-looking equation ...

A man recounts the exact moment ordinary awareness ended. Physical sensation dropped away suddenly. Consciousness remained clear despite the loss of bodily control. Time felt altered almost ...

Abbott made one of the biggest deals in recent medtech history last week when it announced its plan to acquire Exact Sciences — maker of colon cancer screening test Cologuard — for $23 billion.

Abbott is getting into cancer testing with its $21 billion acquisition Exact Sciences, the maker of the game-changing colorectal cancer test Cologuard. Abbott markets well-known diagnostics for ...

It was Bloomberg that first reported rumors of the buyout on Wednesday, citing that talks were nearing fruition, according to people familiar with the matter. At the time of the article, Exact only ...